Headline News about Halozyme Therapeutic
![](https://cdn.benzinga.com/files/images/story/2022/08/02/biotech4.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/24/david-gabric-kdc5agsz6ik-unsplash6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/23/cytonn-photography-vwchrczcqwm-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3968.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_1655.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6225.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_2913.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/08/srne_doctor_oncology_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/13/stethoscope-g51e601cf2_1920.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/merger-businessman-handshake.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/13/chart16.jpg)
![](https://www.investors.com/wp-content/uploads/2018/04/stock-glaxo-smith-kline-03-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/13/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/13/nyse_trading_floor-wikimedia.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/13/halozyme_therapeutics_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/08/aapharma_6.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3934.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3614.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_1723.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech7.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5842.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_392.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/pharma-stocks.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2695.png)
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
December 02, 2021
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2363.png)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Halozyme Therapeutics, inc (HALO) Q3 2021 Earnings Call Transcript
November 03, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/virus-4030721_1920_10.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.